Drug Discovery - Medicine.net

Drug Discovery

Sub Categories on Drug Discovery

{{items.name}}

Latest Articles

How breast cancer cells become dormant and remain undetected for years, and why they later wake up and metastasize

How breast cancer cells become dormant and remain undetected for years, and why they later wake up and metastasize

Updated on: May 18,2025

How breast cancer cells become dormant and remain undetected for years, and why they later wake up and metastasize

How breast cancer cells become dormant and remain undetected for years, and why they later wake up and metastasize

Updated on:May 18,2025

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on: October 05,2025

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on:October 05,2025

Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics

Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics

Updated on: October 03,2025

Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics

Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics

Updated on:October 03,2025

Weekly Update of Drug News-3/11/2025

Weekly Update of Drug News-3/11/2025

Updated on: November 03,2025

Weekly Update of Drug News-3/11/2025

Weekly Update of Drug News-3/11/2025

Updated on:November 03,2025

Is multicancer testing valuable? Questions to ask before getting screened

Is multicancer testing valuable? Questions to ask before getting screened

Updated on: October 05,2025

Is multicancer testing valuable? Questions to ask before getting screened

Is multicancer testing valuable? Questions to ask before getting screened

Updated on:October 05,2025

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Updated on: October 04,2025

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Updated on:October 04,2025

FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression

FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression

Updated on: July 12,2025

FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression

FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression

Updated on:July 12,2025

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Updated on: October 04,2025

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Updated on:October 04,2025

Clinical trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

Clinical trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

Updated on: October 05,2025

Clinical trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

Clinical trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

Updated on:October 05,2025

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

Updated on: October 05,2025

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

Updated on:October 05,2025

Categories

Allergy&Clinical immunology

Anesthesiology & Pain

Cardiovascular Diseases

Diabetes & Endocrinology

Emergency Medicine & Critical Care

Family Medicine

Gastroenterology

General Surgery

Hematology&Oncology

Infectious Diseases

Nephrology & Urology

Orthopedics & Sports medicine

Plastic Surgery

Psychiatry & Mental Health

Public Health & Prevention